Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 2
2007 1
2008 3
2009 1
2014 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Elbow Evaluation Via Telephone and Video Visit.
Vomer RP 2nd, Carfagno D, Lewno A, Shah NP, Farford BA, Kieneker L, Pujalte GGA. Vomer RP 2nd, et al. Among authors: carfagno d. Cureus. 2023 Jun 1;15(6):e39843. doi: 10.7759/cureus.39843. eCollection 2023 Jun. Cureus. 2023. PMID: 37397649 Free PMC article.
Prevalence of Cardiovascular Disease and Risk Factors Among Former National Football League Players.
Okoh AK, Amponsah MKD, Cheffet-Walsh S, Patel M, Carfagno D, Linton D, Dimeff R, Braunreiter D, Harrington P, Brennan FH Jr, Kavinsky C, Everett M, Park B, Gunnarsson M, Snowden S, Mootz L, Koepnick T, Wheeler J, Clarke SE, Prince H, Sannino A, Grayburn P, Rice EL. Okoh AK, et al. Among authors: carfagno d. J Am Coll Cardiol. 2024 May 14;83(19):1827-1837. doi: 10.1016/j.jacc.2024.03.371. Epub 2024 Apr 7. J Am Coll Cardiol. 2024. PMID: 38593943 Free article.
Metabolic testing in the office.
Carfagno DG, Yusin J, Knowlton L. Carfagno DG, et al. Curr Sports Med Rep. 2008 May-Jun;7(3):163-70. doi: 10.1097/01.CSMR.0000319705.95180.80. Curr Sports Med Rep. 2008. PMID: 18477875
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Genovese MC, Kaine JL, Lowenstein MB, Del Giudice J, Baldassare A, Schechtman J, Fudman E, Kohen M, Gujrathi S, Trapp RG, Sweiss NJ, Spaniolo G, Dummer W; ACTION Study Group. Genovese MC, et al. Arthritis Rheum. 2008 Sep;58(9):2652-61. doi: 10.1002/art.23732. Arthritis Rheum. 2008. PMID: 18759293 Free article. Clinical Trial.
11 results